| Peer-Reviewed

Choroidal Metastasis of the Mucinous Rectal Adenocarcinoma

Received: 7 May 2022     Accepted: 25 June 2022     Published: 20 July 2022
Views:       Downloads:
Abstract

Our purpose was to evaluate the uveal metastasis causing progressive vision loss in the advanced rectal cancer. In our case, 34 years old male patient has consulted to our clinic by medical oncology department because of right blurred vision. He was primary mucinous rectum cancer patient and also has lung and vertebral metastasis. The most common intraocular malignant tumors are uveal metastasis. Especially in severe and advanced cancer patients, there may be seen some metastasis and approximately 10% of these metastasis can be seen in choroid. On the other hand, first sign of a metastatic primary tumor can be an uveal metastasis, that’s why it is important to research for primary origin. Extraocular malignant cancers may metastate intraocular, but this event is rare. Intraocular metastasis can be seen in the uveal tract, mostly in the choroid and they are the most common type of intraocular malignancies. Choroidal metastasis is seen like a creamy white or pale yellow mass associated with subretinal fluid. The most common primary origins are breast cancer in female and lung cancer in male patients. They can be diagnose by ultrasonography (USG) and optical coherence tomography (OCT). Intraocular biopsy is useful in patients with clinical suspicion of uveal metastasis but no evidence of primary malignancy despite systemic evaluation. If systemic treatment is not enough to supress the ocular tumor, local therapies such as external beam radiation therapy (EBRT), photodynamic therapy (PDT), and transpupillary thermotherapy (TPT) may be tried. Unfortunately, the survival rate of these patients is low after diagnosis.

Published in International Journal of Medical Case Reports (Volume 1, Issue 3)
DOI 10.11648/j.ijmcr.20220103.14
Page(s) 25-28
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2022. Published by Science Publishing Group

Keywords

Choroidal Metastasis, Rectum Carcinoma, Vision Loss

References
[1] Shields JA, Shields CL.: Metastatic tumors to the ıntraocular structures. Intraocular tumors: A text and atlas. Philadelphia: WB Saunders, 1992: 207-238.
[2] Shields CL, Shields JA, Gross NE, Schwartz G, Lally S.: Survey of 520 uveal metastases. Ophthalmology 1997: 104; 1265-1276.
[3] Kanthan GL, Jayamahan J, Yip D, Conway RM.: Management of metastatic carcinoma of the uveal tract an evidence-based analysis. Clin Experiment Ophthalmol 2007: 35; 553-565.
[4] Soysal HG.: Metastatic tumors of the uvea in 38 eyes. Can J Ophthalmol 2007: 42: 832-835.
[5] Demirci H, Shields CL, Chao AN, Shields JA.: Uveal metastasis from breast cancer in 264 patients. Am J Ophthalmol 2003: 136; 264-271.
[6] Harbour JW, de Potter P, Shields CL, Shields JA.: Uveal metastasis from carcinoid tumor. Clinical Observations in nine cases. Ophthalmology 1994: 101; 1084-1020.
[7] Wiegel T, Krensel KM, Bornfold N, Bottke D, Stange, Foerster MH, Hinkelbein W.: Frequency of asymptomatic choroidal metastasis in patients with disseminated breast cancer: results of a prospective screening programme, Br J Ophthalmol 1998: 82; 1159-1161.
[8] Mewis L, Young SE.: Breast carcinoma metastatic to the choroid-analysis of 67 patients Ophthalmology 1982: 89; 147-151.
[9] Shields CL.: Plaque radiotherapy for the management of uveal metastasis. Curr Opin Ophthalmol 1998: 9; 31-37.
[10] Konstantinidis L., Damato B.: Intraocular metastasis- A Review. Asia Pac J Ophthalmol 2017 Mar-Apr, 6 (2): 208-214.
[11] Giulari GP, Sadaka A.: Uveal metastatic disease: current and new treatment options (review). Oncol Rep. 2012 Mar; 27 (3): 603-7. doi: 10.3892/or2011.1563.Epub 2011 Nov 28.
[12] Schizas D, Katsaros I, Mastoraki A, Karela NR, Zampetaki D, Lazaridis II, Tsapralis D, Theodoropoulos GE. J Invest Surg. 2022 Jan; 35 (1): 151-156. doi: 10.1080/08941939.2020.1824044. Epub 2020 Oct 6.
[13] Malakhov N, Kim JK, Adedoyin P, Albert A, Schreiber D, Lee A. J Gastrointest Cancer. 2022 Mar; 53 (1): 105-112. doi: 10.1007/s12029-020-00552-3. Epub 2020 Nov 19.
[14] Gonzáles Yovera JG, Vargas Marcacuzco HT, Santos Julian RE, Arenas Gamio JL. Rev Gastroenterol Peru. 2020 Oct-Dec; 40 (4): 361-365.
[15] Arepalli S, Kaliki S, Shields CL. (2015 Feb.) Indian J Ophthalmol. 63 (2): 122-7. doi: 10.4103/0301-4738.154380.
[16] Jegerlehner S, Rothenbuehler SP, Pabst T. Praxis (Bern 1994). (2014 May 21); 103 (11): 641-7. doi: 10.1024/1661-8157/a001671.
[17] Mathis T, Jardel P, Loria O, Delaunay B, Nguyen AM, Lanza F, Mosci C, Caujolle JP, Kodjikian L, Thariat J. Prog Retin Eye Res. 2019 Jan; 68: 144-176. doi: 10.1016/j.preteyeres.2018.09.003. Epub 2018 Sep 19.
[18] Sun Y, Smith LEH. (2018 Sep 15) Annu Rev Vis Sci.; 4: 101-122. doi: 10.1146/annurev-vision-091517-034018.
[19] Campbell JP, Zhang M, Hwang TS, Bailey ST, Wilson DJ, Jia Y, Huang D. (2017 Feb 10) Sci Rep.; 7: 42201. doi: 10.1038/srep42201.
[20] Edwards M, Lutty GA. (2021) Adv Exp Med Biol.; 1256: 89-119. doi: 10.1007/978-3-030-66014-7_4.
Cite This Article
  • APA Style

    Musa Yigit, Levent Tok, Ozlem Yalcın Tok. (2022). Choroidal Metastasis of the Mucinous Rectal Adenocarcinoma. International Journal of Medical Case Reports, 1(3), 25-28. https://doi.org/10.11648/j.ijmcr.20220103.14

    Copy | Download

    ACS Style

    Musa Yigit; Levent Tok; Ozlem Yalcın Tok. Choroidal Metastasis of the Mucinous Rectal Adenocarcinoma. Int. J. Med. Case Rep. 2022, 1(3), 25-28. doi: 10.11648/j.ijmcr.20220103.14

    Copy | Download

    AMA Style

    Musa Yigit, Levent Tok, Ozlem Yalcın Tok. Choroidal Metastasis of the Mucinous Rectal Adenocarcinoma. Int J Med Case Rep. 2022;1(3):25-28. doi: 10.11648/j.ijmcr.20220103.14

    Copy | Download

  • @article{10.11648/j.ijmcr.20220103.14,
      author = {Musa Yigit and Levent Tok and Ozlem Yalcın Tok},
      title = {Choroidal Metastasis of the Mucinous Rectal Adenocarcinoma},
      journal = {International Journal of Medical Case Reports},
      volume = {1},
      number = {3},
      pages = {25-28},
      doi = {10.11648/j.ijmcr.20220103.14},
      url = {https://doi.org/10.11648/j.ijmcr.20220103.14},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijmcr.20220103.14},
      abstract = {Our purpose was to evaluate the uveal metastasis causing progressive vision loss in the advanced rectal cancer. In our case, 34 years old male patient has consulted to our clinic by medical oncology department because of right blurred vision. He was primary mucinous rectum cancer patient and also has lung and vertebral metastasis. The most common intraocular malignant tumors are uveal metastasis. Especially in severe and advanced cancer patients, there may be seen some metastasis and approximately 10% of these metastasis can be seen in choroid. On the other hand, first sign of a metastatic primary tumor can be an uveal metastasis, that’s why it is important to research for primary origin. Extraocular malignant cancers may metastate intraocular, but this event is rare. Intraocular metastasis can be seen in the uveal tract, mostly in the choroid and they are the most common type of intraocular malignancies. Choroidal metastasis is seen like a creamy white or pale yellow mass associated with subretinal fluid. The most common primary origins are breast cancer in female and lung cancer in male patients. They can be diagnose by ultrasonography (USG) and optical coherence tomography (OCT). Intraocular biopsy is useful in patients with clinical suspicion of uveal metastasis but no evidence of primary malignancy despite systemic evaluation. If systemic treatment is not enough to supress the ocular tumor, local therapies such as external beam radiation therapy (EBRT), photodynamic therapy (PDT), and transpupillary thermotherapy (TPT) may be tried. Unfortunately, the survival rate of these patients is low after diagnosis.},
     year = {2022}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Choroidal Metastasis of the Mucinous Rectal Adenocarcinoma
    AU  - Musa Yigit
    AU  - Levent Tok
    AU  - Ozlem Yalcın Tok
    Y1  - 2022/07/20
    PY  - 2022
    N1  - https://doi.org/10.11648/j.ijmcr.20220103.14
    DO  - 10.11648/j.ijmcr.20220103.14
    T2  - International Journal of Medical Case Reports
    JF  - International Journal of Medical Case Reports
    JO  - International Journal of Medical Case Reports
    SP  - 25
    EP  - 28
    PB  - Science Publishing Group
    SN  - 2994-7049
    UR  - https://doi.org/10.11648/j.ijmcr.20220103.14
    AB  - Our purpose was to evaluate the uveal metastasis causing progressive vision loss in the advanced rectal cancer. In our case, 34 years old male patient has consulted to our clinic by medical oncology department because of right blurred vision. He was primary mucinous rectum cancer patient and also has lung and vertebral metastasis. The most common intraocular malignant tumors are uveal metastasis. Especially in severe and advanced cancer patients, there may be seen some metastasis and approximately 10% of these metastasis can be seen in choroid. On the other hand, first sign of a metastatic primary tumor can be an uveal metastasis, that’s why it is important to research for primary origin. Extraocular malignant cancers may metastate intraocular, but this event is rare. Intraocular metastasis can be seen in the uveal tract, mostly in the choroid and they are the most common type of intraocular malignancies. Choroidal metastasis is seen like a creamy white or pale yellow mass associated with subretinal fluid. The most common primary origins are breast cancer in female and lung cancer in male patients. They can be diagnose by ultrasonography (USG) and optical coherence tomography (OCT). Intraocular biopsy is useful in patients with clinical suspicion of uveal metastasis but no evidence of primary malignancy despite systemic evaluation. If systemic treatment is not enough to supress the ocular tumor, local therapies such as external beam radiation therapy (EBRT), photodynamic therapy (PDT), and transpupillary thermotherapy (TPT) may be tried. Unfortunately, the survival rate of these patients is low after diagnosis.
    VL  - 1
    IS  - 3
    ER  - 

    Copy | Download

Author Information
  • Ophthalmology Clinic, Isparta ?ehir Hospital, Isparta, Turkey

  • Ophthalmology Clinic, Süleyman Demirel University, Isparta, Turkey

  • Sections